Genetic issues in the syndrome of minimal brain dysfunction.
D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy / Q000453:epidemiology / Q000235:genetics* / Q000378:metabolism; D003913:Dextroamphetamine / Q000378:metabolism / Q000627:therapeutic use; D004200:Diseases in Twins; D005260:Female; D006801:Humans; D006948:Hyperkinesis / Q000235:genetics; D007099:Imipramine / Q000627:therapeutic use; D008607:Intellectual Disability / Q000235:genetics; D007859:Learning Disabilities / Q000235:genetics; D008297:Male; D008774:Methylphenidate / Q000009:adverse effects / Q000627:therapeutic use; D010641:Phenotype; D012737:Sex Factors; D019966:Substance-Related Disorders / Q000209:etiology; D014481:United States
D008774:Methylphenidate; D007099:Imipramine; D003913:Dextroamphetamine